| Original language | English (US) |
|---|---|
| Journal | JAMA Internal Medicine |
| DOIs |
|
| State | Published - Jan 1 2019 |
Fingerprint
Cholinergic Antagonists
Alzheimer Disease
Deprescriptions
ASJC Scopus subject areas
- Internal Medicine
Cite this
Campbell, N. L., Holden, R., & Boustani, M. (2019). Preventing Alzheimer Disease by Deprescribing Anticholinergic Medications. JAMA Internal Medicine. https://doi.org/10.1001/jamainternmed.2019.0676
Preventing Alzheimer Disease by Deprescribing Anticholinergic Medications. / Campbell, Noll L.; Holden, Richard; Boustani, Malaz.
In: JAMA Internal Medicine, 01.01.2019.Research output: Contribution to journal › Comment/debate
Campbell NL, Holden R, Boustani M. Preventing Alzheimer Disease by Deprescribing Anticholinergic Medications. JAMA Internal Medicine. 2019 Jan 1. https://doi.org/10.1001/jamainternmed.2019.0676
@article{2de4dfd517bb4a25bfae40e16f46919a,
title = "Preventing Alzheimer Disease by Deprescribing Anticholinergic Medications",
author = "Campbell, {Noll L.} and Richard Holden and Malaz Boustani",
year = "2019",
month = "1",
day = "1",
doi = "10.1001/jamainternmed.2019.0676",
language = "English (US)",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
}
TY - JOUR
T1 - Preventing Alzheimer Disease by Deprescribing Anticholinergic Medications
AU - Campbell, Noll L.
AU - Holden, Richard
AU - Boustani, Malaz
PY - 2019/1/1
Y1 - 2019/1/1
UR - http://www.scopus.com/inward/record.url?scp=85067893032&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85067893032&partnerID=8YFLogxK
U2 - 10.1001/jamainternmed.2019.0676
DO - 10.1001/jamainternmed.2019.0676
M3 - Comment/debate
JO - JAMA Internal Medicine
JF - JAMA Internal Medicine
SN - 2168-6106
ER -